Skip Navigation
Menu
ACP Journal Club |15 September 2009

Review: Aspirin reduces vascular events but increases bleeding in primary and secondary prevention

Debabrata Mukherjee, MD, MS

Article, Author, and Disclosure Information
FULL TEXT
Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-60. 19482214

GIM/FP/GP:

Cardiology:

Neurology:

See alsoReview: Aspirin does not reduce CV events but may reduce nonfatal stroke in peripheral artery disease
Aspirin, first synthesized in 1853 by Charles Frederic Gerhardt, a French chemist, has been widely recommended in recent years for the reduction of adverse CV events. Several studies and previous meta-analyses have suggested that aspirin has substantial benefit in the secondary prevention of CV events (1), but the...
FULL TEXT
PDF
Not Available
Citations
Citation

Mukherjee D. Review: Aspirin reduces vascular events but increases bleeding in primary and secondary prevention. Ann Intern Med. 2009;151:JC3–4. doi: https://doi.org/10.7326/0003-4819-151-6-200909150-02004

Download citation file:

© 2020

×
Permissions

Published: Ann Intern Med. 2009;151(6):JC3-4.

DOI: 10.7326/0003-4819-151-6-200909150-02004

0 Citations

Related Articles
In embolic stroke of undetermined source, rivaroxaban vs aspirin did not reduce recurrence and increased bleeding
Annals of Internal Medicine; 169 (6): JC32
In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone
Annals of Internal Medicine; 167 (10): JC52
In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleeding
Annals of Internal Medicine; 166 (12): JC65
Update in General Internal Medicine: Evidence Published in 2016
Annals of Internal Medicine; 166 (7): W11-W15
View MoreView Less

Journal Club
In embolic stroke of undetermined source, rivaroxaban vs aspirin did not reduce recurrence and increased bleeding
Annals of Internal Medicine; 169 (6): JC32
In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone
Annals of Internal Medicine; 167 (10): JC52
In VTE, extending anticoagulation with rivaroxaban vs aspirin reduced recurrence without increasing bleeding
Annals of Internal Medicine; 166 (12): JC65
Pooled RCTs: After ischemic stroke or TIA, aspirin for secondary prevention reduced early recurrence and severity
Annals of Internal Medicine; 165 (6): JC27
View MoreView Less

Related Point of Care
Acute Gastrointestinal Bleeding
Annals of Internal Medicine; 159 (3): ITC2-1
View MoreView Less

Related Topics
Prevention/Screening

Prevention/Screening.

PubMed Articles
[Status of the clopidogrel use in ACS patients and related factors among county hospitals in China].
Zhonghua Xin Xue Guan Bing Za Zhi 2019;47(12):985-992.
The management of infective endocarditis complicated by stroke.
Int J Clin Pract 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×